Virbac Yönetim

Yönetim kriter kontrolleri 4/4

Virbac CEO'su Habib Ramdani, Jun2016 tarihinde atandı, in görev süresi 8.42 yıldır. in toplam yıllık tazminatı € 442.92K olup, şirket hissesi ve opsiyonları dahil olmak üzere 55.3% maaş ve 44.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.014% ine doğrudan sahiptir ve bu hisseler € 388.83K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.7 yıl ve 3.9 yıldır.

Anahtar bilgiler

Habib Ramdani

İcra Kurulu Başkanı

€442.9k

Toplam tazminat

CEO maaş yüzdesi	55.3%
CEO görev süresi	8.4yrs
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	3.7yrs
Yönetim Kurulu ortalama görev süresi	3.9yrs

Son yönetim güncellemeleri

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Jun 15

Recent updates

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Jan 18

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Dec 27

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Oct 19

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Sep 26

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Sep 05

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Jun 20

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

May 31

Is Virbac (EPA:VIRP) Using Too Much Debt?

Apr 09

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Feb 28

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

Aug 07

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Jun 26

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

May 01

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Mar 26

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jan 26

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Dec 28

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Oct 27

Is Virbac (EPA:VIRP) Using Too Much Debt?

Oct 12

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Sep 26

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Jul 15

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Jun 27

Is Virbac (EPA:VIRP) A Risky Investment?

May 27

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Mar 24

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Mar 12

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Feb 22

Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Feb 03

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18

CEO Tazminat Analizi

Habib Ramdani'un ücretlendirmesi Virbac'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	€141m
Mar 31 2024	n/a	n/a	€131m
Dec 31 2023	€443k	€245k	€121m
Sep 30 2023	n/a	n/a	€120m
Jun 30 2023	n/a	n/a	€119m
Mar 31 2023	n/a	n/a	€121m
Dec 31 2022	€395k	€233k	€122m
Sep 30 2022	n/a	n/a	€120m
Jun 30 2022	n/a	n/a	€119m
Mar 31 2022	n/a	n/a	€116m
Dec 31 2021	€458k	€227k	€113m
Sep 30 2021	n/a	n/a	€137m
Jun 30 2021	n/a	n/a	€161m
Mar 31 2021	n/a	n/a	€148m
Dec 31 2020	€311k	€222k	€136m
Sep 30 2020	n/a	n/a	€104m
Jun 30 2020	n/a	n/a	€72m
Mar 31 2020	n/a	n/a	€62m
Dec 31 2019	€299k	€213k	€52m
Sep 30 2019	n/a	n/a	€43m
Jun 30 2019	n/a	n/a	€34m
Mar 31 2019	n/a	n/a	€27m
Dec 31 2018	€400k	€203k	€20m
Sep 30 2018	n/a	n/a	€8m
Jun 30 2018	n/a	n/a	-€4m
Mar 31 2018	n/a	n/a	-€3m
Dec 31 2017	€212k	€203k	-€3m

Tazminat ve Piyasa: Habib 'nin toplam tazminatı ($USD 464.03K ), French pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 2.50M ).

Tazminat ve Kazançlar: Habib 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Habib Ramdani (48 yo)

8.4yrs

Görev süresi

€442,921

Tazminat

Mr. Habib Ramdani servesa s Interim CEO of Virbac SA from July 2024. He has been Chief Financial Officer at Virbac SA since June 30, 2016 and serves as its Deputy Chief Executive Officer since December 15,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Habib Ramdani	Interim CEO & CFO	8.4yrs	€442.92k	0.014% € 388.8k
Marc Bistuer	Deputy CEO and Head of Compliance & Corporate Quality Assurance	1.8yrs	€396.22k	0.088% € 2.4m
Sandrine Brunel	Head of Corporate Communications	no data	Veri yok	Veri yok
Nathalie Pollet	Head of Global Marketing & Market Development	3.8yrs	Veri yok	Veri yok
Francesca Cortella	Head of Corporate Human Resources	9.8yrs	Veri yok	Veri yok
Sophie Favini	Head of Global Business Operations	2.8yrs	Veri yok	Veri yok
Bertrand Havrileck	Head of Corporate R&D	3.6yrs	Veri yok	Veri yok
André Mathieu	Head of Global Industrial Operations	no data	Veri yok	Veri yok
Manuela Rodríguez	Director of Financial Projects	no data	Veri yok	Veri yok

3.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim: VIRP 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Pierre Madelpuech	Vice Chairman of the Board of Directors	3.9yrs	€27.00k	0.0013% € 35.5k
Marie-Helene Dick-Madelpuech	Chairwoman of Board of Directors	3.9yrs	€137.00k	50.19% € 1.4b
Xavier Yon	Non-Voting Advisor	no data	€24.00k	Veri yok
Olivier Charmeil	Independent Director	less than a year	Veri yok	0.00012% € 3.3k
Philippe Gaston Capron	Member of Board of Directors	3.9yrs	€30.00k	0.0053% € 143.3k
Cyrille Petit	Independent Member of Board of Directors	3.9yrs	€27.00k	0.0031% € 84.1k
Solene Madelpuech	Members of the Board of Directors	3.9yrs	€27.00k	0.00012% € 3.3k
Sylvie Gueguen	Employee Representative Director	3.9yrs	Veri yok	0.0016% € 44.8k
Rodolphe Durand	Non-Voting Advisor	no data	€24.00k	Veri yok

3.9yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: VIRP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).

Virbac Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Virbac Sa Announces Chief Executive Officer Changes

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Virbac SA, Annual General Meeting, Jun 21, 2021

Recent updates

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 47% Undervalued

Virbac SA Just Beat Revenue Estimates By 6.0%

Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Virbac SA Revises Earnings Guidance for the Fiscal Year 2024

Virbac Sa Announces Chief Executive Officer Changes

Upcoming dividend of €1.32 per share

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Dividend of €1.32 announced

Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

Full year 2023 earnings released: EPS: €14.40 (vs €14.43 in FY 2022)

Virbac SA (ENXTPA:VIRP) acquired Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591).

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Full year 2023 earnings: EPS misses analyst expectations

Virbac SA (ENXTPA:VIRP) entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591) for an enterprise value of approximately €280 million.

Virbac SA Provides Earnings Guidance for the Year 2024

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Now 21% undervalued

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Virbac SA to Report Fiscal Year 2023 Results on Mar 19, 2024

Price target increased by 11% to €327

Investor sentiment improves as stock rises 15%

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

First half 2023 earnings released: EPS: €8.86 (vs €9.18 in 1H 2022)

Virbac SA Confirms Revenue Forecasts for the Year 2023

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Upcoming dividend of €1.32 per share at 0.5% yield

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

Is Virbac (EPA:VIRP) Using Too Much Debt?

Full year 2022 earnings released: EPS: €14.44 (vs €13.40 in FY 2021)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA to Report First Half, 2023 Results on Sep 14, 2023

Virbac SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Price target decreased to €341

Investor sentiment deteriorated over the past week

Price target decreased to €348

Virbac SA Provides Revenue Guidance for the Year 2022

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: €9.18 (vs €8.54 in 1H 2021)

Investor sentiment deteriorated over the past week

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Upcoming dividend of €1.25 per share

Full year 2021 earnings: EPS exceeds analyst expectations

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Virbac SA Provides Revenue Guidance for the Year 2022

Price target increased to €435

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Price target increased to €416

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Price target increased to €367

Virbac SA (ENXTPA:VIRP) acquired an additional 15% stake in Centrovet group for $17.7 million.

Price target increased to €341

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Consensus EPS estimates increase to €10.34

Price target increased to €305

Virbac SA Raises Revenue Guidance for 2021

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Upcoming dividend of €0.75 per share

Is Virbac (EPA:VIRP) A Risky Investment?